Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast Cancer
Condition(s):Triple-negative Breast CancerLast Updated:April 30, 2019Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Triple-negative Breast CancerLast Updated:April 30, 2019Not yet recruiting
Condition(s):Breast CancerLast Updated:February 9, 2017Unknown status
Condition(s):Low-Grade GliomaLast Updated:November 18, 2020Completed
Condition(s):Breast Cancer; Metastatic Breast CancerLast Updated:April 17, 2019Terminated
Condition(s):Breast CancerLast Updated:September 20, 2018Completed
Condition(s):Lung Neoplasm MalignantLast Updated:March 12, 2020Terminated
Condition(s):Breast Cancer; Brain MetastasesLast Updated:May 29, 2019Unknown status
Condition(s):RhabdomyosarcomaLast Updated:May 17, 2022Recruiting
Condition(s):Ovarian Cancer; Fallopian Tube CancerLast Updated:March 29, 2018Unknown status
Condition(s):Multiple Myeloma; AmyloidosisLast Updated:April 3, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.